The North America RNA Analysis Market would witness market growth of 15.1% CAGR during the forecast period (2022-2028).
A cell's identity is determined by the transcription of a subset of its genes into complementary RNA molecules, which also controls the biological processes taking place inside the cell. These are crucial for deciphering the functional components of the genome and comprehending development and illness. The transcriptome is extremely complicated and contains several coding and non-coding RNA species. Historically, according to the fundamental tenet of molecular biology, RNA molecules were considered to be merely an intermediary between genes and proteins.
Because they used the genetic code to encode proteins, messenger RNA molecules were the most widely investigated RNA species. There is a wide variety of noncoding RNA molecules that are functional in addition to protein-coding mRNA. Most ncRNAs were previously thought to perform fundamental cellular tasks, such as those carried out by ribosomal and transfer RNAs in mRNA translation, small nuclear RNAs in splicing, and small nucleolar RNAs that modify rRNAs.
Currently, healthcare providers are seeking ways to streamline their processes, especially concerning planning and invoicing for virtual treatment. As the use, transmission, and availability of digital health information increases, providers are required to implement stronger and more sophisticated cybersecurity measures and encryption to protect patient privacy. A significant market may exist for platforms that connect to Prescribe IT, Canada's national e-prescription system. The prevalence of chronic diseases and the aging of the population are increasing demand in the Canadian healthcare sector.
The US market dominated the North America RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,226.8 million by 2028. The Canada market is poised to grow at a CAGR of 17.7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 16.7% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global RNA Analysis Market is Estimated to reach $28 Billion by 2028, at a CAGR of 15.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Kits & Reagents
- Instruments
- Services
By Technology
- Real Time-PCR (qPCR) Technology
- Sequencing Technology
- Microarray Technology
- Others
By End-use
- Government Institutes & Academic Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
By Application
- Infectious Diseases & Pathogenesis
- Epigenetics
- RNA Structure & Molecular Dynamics
- Development & Delivery of RNA Therapeutics
- Construction of RNA Expression Atlas
- Alternative RNA Splicing
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific Group
- Merck Group
- Promega Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America RNA Analysis Market, by Product
1.4.2 North America RNA Analysis Market, by Technology
1.4.3 North America RNA Analysis Market, by End-use
1.4.4 North America RNA Analysis Market, by Application
1.4.5 North America RNA Analysis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
Chapter 4. North America RNA Analysis Market by Product
4.1 North America Kits & Reagents Market by Country
4.2 North America Instruments Market by Country
4.3 North America Services Market by Country
Chapter 5. North America RNA Analysis Market by Technology
5.1 North America Real Time-PCR (qPCR) Technology Market by Country
5.2 North America Sequencing Technology Market by Country
5.3 North America Microarray Technology Market by Country
5.4 North America Others Market by Country
Chapter 6. North America RNA Analysis Market by End-use
6.1 North America Government Institutes & Academic Centers Market by Country
6.2 North America Hospitals & Clinics Market by Country
6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
6.4 North America Contract Research Organizations (CROs) Market by Country
Chapter 7. North America RNA Analysis Market by Application
7.1 North America Infectious Diseases & Pathogenesis Market by Country
7.2 North America Epigenetics Market by Country
7.3 North America RNA Structure & Molecular Dynamics Market by Country
7.4 North America Development & Delivery of RNA Therapeutics Market by Country
7.5 North America Construction of RNA Expression Atlas Market by Country
7.6 North America Alternative RNA Splicing Market by Country
7.7 North America Others Market by Country
Chapter 8. North America RNA Analysis Market by Country
8.1 US RNA Analysis Market
8.1.1 US RNA Analysis Market by Product
8.1.2 US RNA Analysis Market by Technology
8.1.3 US RNA Analysis Market by End-use
8.1.4 US RNA Analysis Market by Application
8.2 Canada RNA Analysis Market
8.2.1 Canada RNA Analysis Market by Product
8.2.2 Canada RNA Analysis Market by Technology
8.2.3 Canada RNA Analysis Market by End-use
8.2.4 Canada RNA Analysis Market by Application
8.3 Mexico RNA Analysis Market
8.3.1 Mexico RNA Analysis Market by Product
8.3.2 Mexico RNA Analysis Market by Technology
8.3.3 Mexico RNA Analysis Market by End-use
8.3.4 Mexico RNA Analysis Market by Application
8.4 Rest of North America RNA Analysis Market
8.4.1 Rest of North America RNA Analysis Market by Product
8.4.2 Rest of North America RNA Analysis Market by Technology
8.4.3 Rest of North America RNA Analysis Market by End-use
8.4.4 Rest of North America RNA Analysis Market by Application
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
9.10.2.2 Geographical Expansions:
TABLE 1 North America RNA Analysis Market, 2018 - 2021, USD Million
TABLE 2 North America RNA Analysis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– RNA Analysis Market
TABLE 4 Product Launches And Product Expansions– RNA Analysis Market
TABLE 5 Acquisition and Mergers– RNA Analysis Market
TABLE 6 Geographical Expansions – RNA Analysis Market
TABLE 7 North America RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 8 North America RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 9 North America Kits & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Kits & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 15 North America RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 16 North America RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 17 North America Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Sequencing Technology Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Sequencing Technology Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Microarray Technology Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Microarray Technology Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 25 North America RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 26 North America RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 27 North America Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 35 North America RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 36 North America RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 37 North America Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Epigenetics Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Epigenetics Market by Country, 2022 - 2028, USD Million
TABLE 41 North America RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
TABLE 42 North America RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 51 North America RNA Analysis Market by Country, 2018 - 2021, USD Million
TABLE 52 North America RNA Analysis Market by Country, 2022 - 2028, USD Million
TABLE 53 US RNA Analysis Market, 2018 - 2021, USD Million
TABLE 54 US RNA Analysis Market, 2022 - 2028, USD Million
TABLE 55 US RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 56 US RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 57 US RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 58 US RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 59 US RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 60 US RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 61 US RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 62 US RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 63 Canada RNA Analysis Market, 2018 - 2021, USD Million
TABLE 64 Canada RNA Analysis Market, 2022 - 2028, USD Million
TABLE 65 Canada RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 66 Canada RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 67 Canada RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 68 Canada RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 69 Canada RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 70 Canada RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 71 Canada RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 72 Canada RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 73 Mexico RNA Analysis Market, 2018 - 2021, USD Million
TABLE 74 Mexico RNA Analysis Market, 2022 - 2028, USD Million
TABLE 75 Mexico RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 76 Mexico RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 77 Mexico RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 78 Mexico RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 79 Mexico RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 80 Mexico RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 81 Mexico RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 82 Mexico RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 83 Rest of North America RNA Analysis Market, 2018 - 2021, USD Million
TABLE 84 Rest of North America RNA Analysis Market, 2022 - 2028, USD Million
TABLE 85 Rest of North America RNA Analysis Market by Product, 2018 - 2021, USD Million
TABLE 86 Rest of North America RNA Analysis Market by Product, 2022 - 2028, USD Million
TABLE 87 Rest of North America RNA Analysis Market by Technology, 2018 - 2021, USD Million
TABLE 88 Rest of North America RNA Analysis Market by Technology, 2022 - 2028, USD Million
TABLE 89 Rest of North America RNA Analysis Market by End-use, 2018 - 2021, USD Million
TABLE 90 Rest of North America RNA Analysis Market by End-use, 2022 - 2028, USD Million
TABLE 91 Rest of North America RNA Analysis Market by Application, 2018 - 2021, USD Million
TABLE 92 Rest of North America RNA Analysis Market by Application, 2022 - 2028, USD Million
TABLE 93 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 94 Key Information – Danaher Corporation
TABLE 95 key Information – Agilent Technologies, Inc.
TABLE 96 Key Information – Thermo Fisher Scientific, Inc.
TABLE 97 Key Information – Qiagen N.V.
TABLE 98 key information – Illumina, Inc.
TABLE 99 Key Information – Bio-Rad Laboratories, Inc.
TABLE 100 Key Information – Eurofins Scientific Group
TABLE 101 key Information – Merck GrouP
TABLE 102 key Information – Promega Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche AG
FIG 6 Recent strategies and developments: Agilent Technologies, Inc.
FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.
FIG 9 Recent strategies and developments: Illumina, Inc.
FIG 10 Recent strategies and developments: Merck KGaA
FIG 11 Recent strategies and developments: Promega Corporation